Ticker
NRCCompany Name
NATIONAL RESEARCH CORPSector
HealthcareIndustry
Health Information ServicesExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 34.19M | 24.36% | $ 140.31M |
3/31/2025 | $ 41.22M | 29.18% | $ 141.3M |
12/31/2024 | $ 41.31M | 28.87% | $ 143.06M |
9/30/2024 | $ 43.35M | 30.07% | $ 144.15M |
6/30/2024 | $ 45.56M | 31.14% | $ 146.28M |
3/31/2024 | $ 46.32M | 31.42% | $ 147.42M |
12/31/2023 | $ 46.72M | 31.45% | $ 148.58M |
9/30/2023 | $ 44.69M | 30.05% | $ 148.72M |
6/30/2023 | $ 45.37M | 30.56% | $ 148.47M |
3/31/2023 | $ 46.88M | 31.34% | $ 149.6M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NATIONAL RESEARCH CORP is calculated as follows: EBITDA [ $ 50.68M ] / Revenues [ $ 131.13M ]
(=) EBITDA % [ 38.65% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |